ROLE OF NANOTECHNOLOGY IN CURRENT ADVANCEMENT VACCINE DEVELOPMENT FOR COVID-19

R Mohanty

Abstract

The most recent human coronavirus known as COVID-19(SARS-CoV-2) has already spread around the world. This review describes the accumulated knowledge of the previous SARS-CoV, MERS-CoV infections and aim to help understand the newly emerged SARS-CoV-2 infection. Advances in nanotechnology over the past decades to develop new nanomaterials and step forward in the application of new technology tools. Finally nanotechnology approach describes vaccine development and therapeutics drugs developed nanomedicines which are currently undergoing clinical trial to become innovative alternatives for overcoming COVID-19 vaccine. Nanoparticles are non-toxic antiviral showed great promise to provide nano vaccine against viral infection.

Keywords: Nanotechnology, Vaccine Development, COVID-19.

Full Text:

PDF

References

Chen L and Liang J. An Overview of Functional Nanoparticles as Novel Emerging Antiviral Therapeutics Agents. Materials Science and Engineering: C, 2020;112: 110924.

Yan R, Zhang Y, Li Y, Xia L, Guo Y and Zhou Q. Structural Basis for the Recognition of SARS-CoV-2 by Full Length Human ACE-2. Science,2020;367:1444-14448.

Sexton NR, Smith EC, Blanc H, Vignuzzi M, Peerson OB, Denison MR. Homology -Based Identification of a Mutation in the Corona Virus RNA-Dependent RNA Polymerase that Confers Resistance to Multiple Mutagens. J Virol, 2016; 90:7415-7428.

Wrapp D et. al. Cry0-EM Structure of the 2019-nCoV Spike in the Perfusion Conformation. Science, 2020;367:1260-1263.

Zhang JY, Zeng H, Gu J, Li HB, Zheng LX, Zou QM. Progress and prospect on vaccine development against SARS-CoV-2.Vaccines, 2020;8(2):153.

Ma CQ,Wang LL, Tao XR. Searching for an Ideal Vaccine Candidate among Different MERS Coronavirus Receptor Binding Fragments-The Importance of Immuno Focusing in Subunit Vaccine Design. Vaccine,2014;32(46):6170-6176.

Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines- A new era in Vaccinology. Nat Rev Drug Discovery, 2018;17(4):261-279.

Reddy ST, Vander vlies AJ, Simeoni E. Exploiting Lymphatic Transport and Complement Activation in Nanoparticle Vaccines. Nat Biotechnology, 2007;25(10):1159-1164.

Amanna IJ, Raue HP, Slifka MK. Development of a New Hydrogen Peroxide Based Vaccine Platform. Nat Med, 2012;18(6):974.

Kim MG, Park JY, Shon Y, Kim G, Shim G and Oh YK. Nanotechnology and Vaccine Development. Asian Journal of Pharmaceutical Sciences, 2019;10:227-235,

Wang C, Li W, Drabek D, Okha NMA Van, Haperon R, Osterhous ADME et. al. A Human Monoclonal Antibody Blocking SARS-CoV-2 infection. Nat Commun, 2020b;11: 1-6.

Petros RA, De Simone JM, Strategies in the Design of Nanoparticles for therapeutic Applications. Nat Rev Drug Discovery, 2010; 9:615-627.

Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 Vaccine at Pandemic Speed. N Engl J Med, 2020; 382:1969-1973.

Shibata A, McMullen E, Pham A, Belshan M, Sanford B, Zhou Y et. al., Polymeric Nanoparticles Containing Combination Anti-retroviral Drugs for HIV Type 1 Treatment. AIDS Res Hum Retroviruses, 2013; 29:746-754.

Ahn DG, Shin HJ, Kim MH, Lee S, Kim HS, Myoung J, Kim BT, Kim SJ. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Corona Virus Disease 2019 (COVID-19). J. Microbial Biotechnolo 2020; 30:313-324.

Wang G, Pan L, Zhang Y, Wang Y, Zhang Z, Lu J et. al., Intranasal Delivery of Cationic PLGA Nano/Microparticles - Loaded FMDV DNA Vaccine Encoding IL-6 Elicited Protective Immunity against FMDV Challenge. PLoS One 2011; 6:e27605.

Lim M, Badruddoza AZM, Firdous J, Azad M, Mannan A, Al-Hilal T et. al. Engineered Nano Delivery Systems to Improve DNA Vaccine Technologies. Pharmaceutics, 2020;12:30.

Reed SG, Coler RN, Friede M. New Horizons in Adjuvants for Vaccine Development. Trends Immunol, 2009; 30:23-32.

Yoo D, Guk K, HG, Wu D, Lee D. Antioxidant Polymeric Nanoparticles as Novel Therapeutics for Airway Inflammatory Diseases. Int J Pharm, 450:87-94.

Weiss C, Carrier M, Fusco L, Capua I, Regla-Nava JA, Pasquali M et. al., Towards Nanotechnology-enabled Approaches Against the COVID-19 Pandemic. ACS Nano 2020;14:63383-6406.

Roh CA Facile Inhibitor Screening of SARS Coronavirus N Protein using Nanoparticle Based RNA Oligonucleotide. International Journal of Nanomedicine, 2020; 7:2173,2012.

Cui F, Zhou Z and Zhou HS. Molecular Imprinted Polymers and Surface Imprinted Polymers Based Electro-chemical Biosensor for Infectious Disease. Sensor, 2020; 20(4):996,2020.

KimH, Park M, Hwang J et. al., Development of Label-free Calorimetric Assay for MERS-CoV using Gold Nanoparticles. ACS Sensors, 2019;4(5):1306-1312.

Sun J, Lu Y, He L, Pang J and Liu Y. Calorimetric Sensor Array Based on Gold Nanoparticles: Design Principle and Recent Advances.. Trends in analytical Chemistry, 2020; 122:115754,2020.

Shan Z, Zhou Z, Chen H et. al., PCR-Ready Human DNA Extraction from Urine Samples using Magnetic Nanoparticles. Journal of Chromatography B, 2012; 881-882:63-68.

Xu X, Han M, Li T, Sun W,Wang D, Fu B et. al., Surface Engineered Gold Nanorods: Promising DNA Vaccine Adjuvant for HIV-1 Treatment. Nano Lett. 2020;12:2003-2012.

Zacheo A, Hodek J, Witt D, Mangiatordi GF, Ong QK, Kocabiyik O et. al., Multi-Sulfonated Ligand on Gold Nanoparticles as Virucidal Antiviral for Dengue. Virus Sci Rep, 2020; 10:1-9.

Rodriguez MO, Covian LB, Garcia AC, Blanco-Lopez MC. Silver 7 Gold Enhancement Method for Lateral Flow Immunoassays. Talanta, 2016;148:272-278.

Abedi M, Abolmaali SS, Abedanzadeh M, Farjadian F, Mohammadi S and Tamaddon AM. Core-shell Imidazoline-functionalised Mesoporous Silica Super Paramagnetic Hybrid Nanoparticles as a Potential Theranostic Agent for Controlled Delivery of Platinum (II) Compound. Internnational Journal of Nanomedicine, 2020; 15:2617-2631.

Rezaei M, Hosseini SN, Khavari Nejad RA, Najafi F, Mahadavi M. HBs Antigen and Mannose Loading on the Surface of Iron Oxide Nanoparticles in Order to Immune Targeting: Characterisation, Cellular and Humoral Immunoassay. Artif Cells Nanomed Biotechnology, 2019; 47:1543-1558.

Chahal JJ, Khan OF, Cooper CL, McPatlon JS, Tsosil JK, Tilley LD et. al., Dendrim er-RNA Nanoparticles Generate Protective Immunity against Lethal Ebola, H1N1 Influenza, Challenges with a Single Dose. Proc Natt Alad Sci, 2016;113:F4133-F4142.

Puri A, Loomis K, Smith B, Lee JH, Yavlovich A, Heldman E et. al., Lipid based Nanoparticles as Pharmaceutical Drug carriers: From Concepts to Clinic. Crit Rev Ther Drug Carrier Syst, 2009; 26:523-580.

Poon C, Patel AA. Organic and Inorganic Nanoparticle Vaccine for Prevention of Infectious Disease. Nano. Express, 2020:1-11.

Refbacks

  • There are currently no refbacks.


Bookmark and Share